|
|
| p941 |
The angiotensin-converting enzyme 2 in tumor growth and tumor-associated angiogenesis in non-small cell lung cancer |
Yun Feng, Huanying Wan, Jialin Liu, Ruifeng Zhang, Qinyun Ma, Bing Han, Yi Xiang, Jiaming Che, Huangming Cao, Xiaochun Fei, Weicheng Qiu
|
|
|
|
| p957 |
Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma
|
Norio Kondo, Mamoru Tsukuda, Yukari Ishiguro, Machiko Kimura, Kyoko Fujita, Atsuko Sakakibara, Hideaki Takahashi, Gabor Toth, Hideki Matsuda
|
|
|
|
| p965 |
Multidrug resistance-associated protein 2 determines the efficacy of cisplatin in patients with hepatocellular carcinoma
|
Pavel V. Korita, Toshifumi Wakai, Yoshio Shirai, Yasunobu Matsuda, Jun Sakata, Masaaki Takamura, Masahiko Yano, Ayumi Sanpei, Yutaka Aoyagi, Katsuyoshi Hatakeyama, Yoichi Ajioka
|
|
|
|
| p1045 |
Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcome |
David F. Callen, Carmela Ricciardelli, Miriam Butler, Alan Stapleton, Jurgen Stahl, James G. Kench, David J. Horsfall, Wayne D. Tilley, Renee Schulz, Jahn M. Nesland, Paul M. Neilsen, Raman Kumar, Ruth Holm
|
|
|
|
OPEN ACCESS ARTICLE |
| p1077 |
Hyperthermic isolated limb perfusion for recurrent melanomas and soft tissue sarcomas: Feasibility and reproducibility in a multi-institutional Hellenic collaborative study |
Konstantinos Lasithiotakis, George Economou, Helen Gogas, Christos Ioannou, Konstantinos Perisynakis, Dimitrios Filis, Ourania Kastana, Dimitrios Bafaloukos, Marios Decatris, Nikolaos Catodritis, Konstantina Frangia, George Papadakis, Michael Magarakis, Dimosthenis Tsoutsos, Emmanuel Chrysos, George Chalkiadakis, Odysseas Zoras
|
|
|
|
| p1085 |
Human papillomavirus is frequently detected in gefitinib-responsive lung adenocarcinomas |
Michihiro Baba, Andres Castillo, Chihaya Koriyama, Masakazu Yanagi, Hidehiko Matsumoto, Shoji Natsugoe, Karem Y. Shuyama, Noureen Khan, Michiyo Higashi, Tetsuhiko Itoh, Yoshito Eizuru, Takashi Aikou, Suminori Akiba
|
|
|
|
| p1167 |
RAD001 offers a therapeutic intervention through inhibition of mTOR as a potential strategy for esophageal cancer |
Zhi Gang Wang, Takuya Fukazawa, Toshio Nishikawa, Nobuyuki Watanabe, Kazufumi Sakurama, Takayuki Motoki, Shinji Hatakeyama, Osamu Omori, Toshiaki Ohara, Shunsuke Tanabe, Yasuhiro Fujiwara, Munenori Takaoka, Yasuhiro Shirakawa, Tomoki Yamatsuji, Noriaki Tanaka, Yoshio Naomoto
|
|
|
|
|
|